Oral progestogen-only contraceptives and cardiovascular risk: Results from the Transnational Study on Oral Contraceptives and the Health of Young Women

European Journal of Contraception and Reproductive Health Care

Volumn 4, Issue 2, 1999, Pages 67-73

  Heinemann, L A J ^a,b,c   Assmann, A ^a,c   DoMinh, T ^a   Garbe, E ^b   Spitzer, W O ^c   Bergman, U ^c   Breckwoldt, M ^c   Collins, J ^c   Kemper, F ^c   LeLorier, J ^c   MacLeod, S ^c   MacRae, K ^c   Ray, W ^c   Schlesselman, J ^c   Concin, H ^c   Stark, G ^c   Pfeiffer, K ^c   Weitgasser, R ^c   Begaud, B ^c   Boisse, B ^c   Haerting, J ^c   Lautenschlaeger, F ^c   Puschel K ^c   Hoffmann, F ^c   Robra, B P ^c   Lustermann, M ^c   Schulzki, I ^c   Boethig, S ^c   Gutzwiller, F ^c   De Caestecker, L ^c   McCollum, C ^c   Hannaford, P ^c   Mann, R ^c   Lewis, M ^c   Kuhl Habich D ^c   Klindworth, C ^c   more..

^a Ctr for Epidemiol and Hlth Res   (Germany)

^b Potsdam Inst Phar/Tech Assess   (Germany)

^c NONE

Author keywords

Cardiovascular risk; Case control study; Oral contraceptives; Progestogen only pills

Indexed keywords

GESTAGEN; ORAL CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; HUMAN; HYPERTENSION; ORAL CONTRACEPTION; PRIORITY JOURNAL; SMOKING; STROKE;

EID: 0033028689     PISSN: 13625187     EISSN: None     Source Type: Journal    
DOI: 10.3109/13625189909064007     Document Type: Article

References (13)

1. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Cardiovascular disease and use of oral and injectable progestogen-only contraception and combined injectable contraceptives. Contraception 1998; 57: 315-24
2. Spitzer WO, Thorogood M, Heinemann L. Trinational case-control study of oral contraceptives and health. Pharmacoepidemiol Drug Saf 1993; 2: 21-31
3. Lewis MA, Assmann A, Heinemann L, et al. Trinational case-control study of oral contraceptives and health. Approved protocol revision through September 1995. Pharmacoepidemiol Drug Saf 1996; 5: 43-51
4. Lewis MA, Spitzer WO, Heinemann LAJ, et al.: Transnational Research Group on Oral Contraception and the Health of Young Women. Third generation oral contraceptives and risk of myocardial infarction: An international case-control study. Br Med J 1996; 312: 88-90
5. Lewis MA, Heinemann LAJ, Spitzer WO, et al. The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results from the Transnational Study on Oral Contraceptives and the Health of Young Women. Contraception 1997; 56: 129-40
6. Heinemann LAJ, Lewis MA, Thorogood M, et al. Case-control study of oral contraceptives and risk of thromboembolic stroke: Results from international study on oral contraceptives and health of young women. Br Med J 1997; 315: 1502-4
7. Heinemann LAJ, Lewis MA, Spitzer WO, et al. Thromboembolic stroke in young women. Contraception 1998; 57: 29-37
8. Spitzer WO, Lewis MA, Heinemann LAJ, et al.: Transnational Research Group on Oral Contraception and the Health of Young Women. Third generation oral contraceptives and risk of venous thromboembolic disorders: An international case-control study. Br Med J 1996; 312: 83-8
9. STATA. Statistical Software Package Version 4.0. East Station, Texas: Stata Press, 1996
10. Lidegaard O. Oral contraception and risk of cerebral thromboembolic attacks: Results of a case-control study. Br Med J 1993; 306: 956-63
11. Fzourio C, Tehindrazanarivelo A, Iglesias S, et al. Case-control study of migraine and risk of ischemic stroke in young women. Br Med J 1995; 310: 830-3
12. Fetith DB, Siscovick DS, Sidney S, et al. Norplant implants and cardiovascular disease. Contraception 1998; 57: 361-2
13. Fraser IS, Tiitinen A, Affandi B, et al. Norplant consensus statement and background review. Contraception 1998; 57: 1-9